| GILD |
Gilead Sciences, Inc. |
115.85B |
5.36% |
|
|
|
|
|
92.96 |
1.22% |
24.35% |
38.35% |
|---|
| UTHR |
United Therapeutics Corporation |
16.43B |
5.03% |
|
|
|
|
|
367.97 |
2.52% |
31.02% |
56.75% |
|---|
| NTRA |
Natera, Inc. |
22.11B |
5.02% |
|
|
|
|
|
167.46 |
5.75% |
47.13% |
21.76% |
|---|
| BIIB |
Biogen Inc. |
20.54B |
4.91% |
|
|
|
|
|
140.98 |
0.31% |
37.19% |
62.53% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
74.33B |
4.90% |
|
|
|
|
|
687.80 |
0.91% |
35.86% |
61.72% |
|---|
| INCY |
Incyte Corporation |
14.15B |
4.85% |
|
|
|
|
|
73.47 |
2.14% |
49.14% |
59.28% |
|---|
| ILMN |
Illumina, Inc. |
22.41B |
4.85% |
|
|
|
|
|
141.31 |
3.40% |
39.88% |
20.68% |
|---|
| AMGN |
Amgen Inc. |
147.72B |
4.60% |
|
|
|
|
|
274.81 |
0.99% |
27.86% |
24.94% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
14.77B |
3.08% |
|
|
|
|
|
145.88 |
1.83% |
39.33% |
38.71% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
1.58B |
2.98% |
|
|
|
|
|
7.61 |
2.15% |
47.41% |
14.86% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.16B |
2.98% |
|
|
|
|
|
116.79 |
-1.03% |
34.27% |
-1.41% |
|---|
| EXAS |
Exact Sciences Corporation |
10.04B |
2.93% |
|
|
|
|
|
54.26 |
4.87% |
52.85% |
26.11% |
|---|
| QGEN |
Qiagen N.V. |
10.54B |
2.92% |
|
|
|
|
|
47.50 |
3.26% |
42.26% |
61.53% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
11.92B |
2.89% |
|
|
|
|
|
62.53 |
1.63% |
30.53% |
24.93% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.98B |
2.88% |
|
|
|
|
|
17.89 |
1.82% |
41.92% |
23.75% |
|---|
| MNKD |
MannKind Corporation |
1.67B |
2.85% |
|
|
|
|
|
6.04 |
0.50% |
108.16% |
19.64% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
2.73B |
2.85% |
|
|
|
|
|
22.92 |
0.61% |
40.85% |
22.29% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.12B |
2.83% |
|
|
|
|
|
55.94 |
2.08% |
36.82% |
16.72% |
|---|
| TECH |
Bio-Techne Corporation |
12.51B |
2.76% |
|
|
|
|
|
78.75 |
3.85% |
37.33% |
32.56% |
|---|
| VCYT |
Veracyte, Inc. |
3.38B |
2.74% |
|
|
|
|
|
43.60 |
7.44% |
65.09% |
8.64% |
|---|
| RPRX |
Royalty Pharma plc |
13.46B |
2.71% |
|
|
|
|
|
30.30 |
-1.46% |
26.06% |
13.15% |
|---|
| BPMC |
Blueprint Medicines Corporation |
7.11B |
2.68% |
|
|
|
|
|
111.96 |
1.74% |
71.64% |
50.84% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
1.07B |
2.66% |
|
|
|
|
|
33.19 |
-0.48% |
121.06% |
60.78% |
|---|
| TGTX |
TG Therapeutics, Inc. |
4.65B |
2.64% |
|
|
|
|
|
29.86 |
1.05% |
63.01% |
35.61% |
|---|
| XNCR |
Xencor, Inc. |
1.43B |
2.62% |
|
|
|
|
|
20.45 |
6.29% |
128.99% |
67.83% |
|---|
| EXEL |
Exelixis, Inc. |
10.40B |
2.61% |
|
|
|
|
|
36.43 |
0.64% |
34.72% |
24.39% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.66B |
2.50% |
|
|
|
|
|
96.18 |
4.62% |
44.47% |
15.98% |
|---|
| CDNA |
CareDx, Inc |
1.22B |
2.46% |
|
|
|
|
|
22.70 |
5.88% |
84.88% |
12.54% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.27B |
2.41% |
|
|
|
|
|
38.10 |
3.48% |
81.06% |
55.70% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.14B |
2.40% |
|
|
|
|
|
12.57 |
1.45% |
122.23% |
70.30% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.08% |
|
|
|
|
|
|
|
|
|
|---|